We are live on ! Find out more
CC

Checkpoint Capital Portfolio holdings

AUM $279M
1-Year Est. Return 45.74%
This Fund
S&P 500
This Quarter Est. Return
+52.71%
1 Year Est. Return
+45.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$165M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow %
83.59%
Top 10 Hldgs %
90.27%
Holding
19
New
19
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$32.6M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$23M
3
AXSM icon
Axsome Therapeutics
AXSM
+$10.4M
4
SWTX
SpringWorks Therapeutics
SWTX
+$8.87M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$8.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 86.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYTM icon
1
Rhythm Pharmaceuticals
RYTM
$7.96B
$33.6M 20.33%
+730,000
New +$23M
ARGX icon
2
argenx
ARGX
$54.1B
$26.6M 16.13%
+70,000
New +$32.6M
CYTK icon
3
Cytokinetics
CYTK
$10.4B
$19.2M 11.63%
+230,000
New +$8.33M
XBI icon
4
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$16.1M 9.74%
+180,000
New +$13.4M
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
$12.4M 7.52%
+340,000
New +$8.87M
AXSM icon
6
Axsome Therapeutics
AXSM
$10.9B
$12.4M 7.49%
+155,346
New +$10.4M
IRWD icon
7
Ironwood Pharmaceuticals
IRWD
$714M
$10.1M 6.1%
+880,000
New +$8.7M
MIRM icon
8
Mirum Pharmaceuticals
MIRM
$6.14B
$6.9M 4.18%
+233,659
New +$7.07M
PTGX icon
9
Protagonist Therapeutics
PTGX
$9.44B
$6.12M 3.71%
+266,856
New +$4.67M
IRWD icon
10
CALL
Ironwood Pharmaceuticals
IRWD
$714M
$5.72M 3.46%
+500,000
New +$4.95M
AVDL
11
DELISTED
Avadel Pharmaceuticals
AVDL
$4.59M 2.78%
+325,000
New +$3.82M
PHAT icon
12
Phathom Pharmaceuticals
PHAT
$692M
$3.28M 1.99%
+359,446
New +$3.1M
ATYR
13
aTyr Pharma
ATYR
$50.1M
$2.12M 1.28%
+1,503,554
New +$1.93M
TRVI icon
14
Trevi Therapeutics
TRVI
$2.64B
$1.73M 1.05%
+1,292,316
New +$1.96M
GHRS icon
15
GH Research
GHRS
$2.08B
$1.7M 1.03%
+293,945
New +$2.08M
ALLK
16
DELISTED
Allakos
ALLK
$1.21M 0.74%
+444,804
New +$1M
IRON icon
17
Disc Medicine
IRON
$2.97B
$578K 0.35%
+10,000
New +$512K
ACRS icon
18
Aclaris Therapeutics
ACRS
$869M
$476K 0.29%
+453,614
New +$1.38M
EWTX icon
19
Edgewise Therapeutics
EWTX
$4.73B
$361K 0.22%
+33,000
New +$232K

Similar funds

CB
Centennial Bank Conway, Arkansas $279M AUM 20.11% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
BWG
Balanced Wealth Group Westlake, Ohio $279M AUM 17.49% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Checkpoint Capital's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Checkpoint Capital, which disclosed 19 positions worth $165M. Its ten largest holdings account for 90% of the portfolio.

Its largest position is argenx: 70,000 shares worth $26.6M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets.

  • Checkpoint Capital's largest Q4 2023 buy was argenx: 70,000 shares worth $26.6M.
  • Checkpoint Capital's ten largest holdings make up 90% of its $165M portfolio in Q4 2023.
  • Checkpoint Capital disclosed 19 positions in Q4 2023, its first 13F filing on record.

Based on Checkpoint Capital's 13F filing for Q4 2023, filed 14 Feb 2024.